SGLT2 inhibition reduces myocardial oxygen consumption

AIMS/HYPOTHESIS: SGLT2 inhibition is associated with a reduced risk of cardiac disease that is still largely unexplained. According to one hypothesis, improved myocardial energetics may explain the cardioprotective effects of SGLT2i. However, recent mechanistic studies that have addressed this quest...

Descripción completa

Detalles Bibliográficos
Autores principales: Søndergaard, Esben, Lauritzen, Esben S., Lauritsen, Katrine M., Åkerblom, Axel, Nuutila, Pirjo, Oldgren, Jonas, Gormsen, Lars C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Brief Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460164/
https://www.ncbi.nlm.nih.gov/pubmed/36092797
http://dx.doi.org/10.1016/j.metop.2022.100207

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9460164/
https://www.ncbi.nlm.nih.gov/pubmed/36092797
http://dx.doi.org/10.1016/j.metop.2022.100207

Ejemplares similares